Suppr超能文献

真性红细胞增多症后急性淋巴细胞白血病

Acute lymphoid leukemia following polycythemia vera.

作者信息

Camós M, Cervantes F, Montoto S, Hernández-Boluda J C, Villamor N, Montserrat E

机构信息

Postgraduate School of Hematology, Farreras Valenti, Hematology Department, IDIBAPS, Hospital Clínic, Barcelona, Spain.

出版信息

Leuk Lymphoma. 1999 Jan;32(3-4):395-8. doi: 10.3109/10428199909167404.

Abstract

The tendency to evolve into acute leukemia is a well-known characteristic of polycythemia vera (PV), which is shared with the remaining chronic myeloproliferative disorders and increases after the administration of cytotoxic agents. Acute transformation is usually of myeloid phenotype, whereas acute lymphoid leukemia (ALL) following PV is seldom observed. A 63-year-old woman is described who developed ALL at 6 years from the initial diagnosis of PV, for which she had received radioactive phosphorus and hydroxyurea. The ALL was of B-cell type, corresponding to the L-3 subtype of the FAB classification. Despite the administration of combination chemotherapy the patient died shortly after the diagnosis of acute leukemia. The present case adds to seven previously described patients with the above association, all of whom had received cytotoxic therapy for PV. Median interval from PV to ALL diagnosis was 10 years, and there was a predominance of the B-cell phenotype. The prognosis was poor since all but one of the patients had a short survival after ALL diagnosis. The possible etiological and pathogenetic link between PV and the subsequent ALL is discussed.

摘要

演变为急性白血病的倾向是真性红细胞增多症(PV)的一个众所周知的特征,其他慢性骨髓增殖性疾病也有此特征,且在给予细胞毒性药物后会增加。急性转化通常为髓系表型,而PV后发生急性淋巴细胞白血病(ALL)的情况很少见。本文描述了一名63岁女性,她在初次诊断为PV 6年后发生了ALL,期间接受过放射性磷和羟基脲治疗。该ALL为B细胞型,符合FAB分类的L-3亚型。尽管给予了联合化疗,但患者在急性白血病诊断后不久死亡。本病例补充了之前描述的7例有上述关联的患者,他们均接受过PV的细胞毒性治疗。从PV到ALL诊断的中位间隔时间为10年,且以B细胞表型为主。由于除1例患者外,所有患者在ALL诊断后的生存期都很短,故预后较差。本文讨论了PV与后续ALL之间可能的病因学和发病机制联系。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验